SOPHiA GENETICS enters collaboration with Memorial Sloan Kettering Cancer Center and AstraZeneca to address global inequalities in cancer care
SOPHiA GENETICS, a global leader in data-driven medicine will collaborate with Memorial Sloan Kettering Cancer Center (MSK), a top cancer treatment and research institution, and AstraZeneca to advance health equity on a global scale by providing inclusive access to comprehensive cancer testing worldwide.